Gregory Y. Lauwers

Active 1992–2025

197
Papers
39,763
Citations
108
h-index
190
i10-index

Citations

Citations per year for Gregory Y. Lauwers1992: 2 citations1993: 6 citations1994: 3 citations1995: 6 citations1996: 8 citations1997: 17 citations1998: 21 citations1999: 18 citations2000: 19 citations2001: 40 citations2002: 46 citations2003: 61 citations2004: 130 citations2005: 165 citations2006: 251 citations2007: 341 citations2008: 345 citations2009: 431 citations2010: 481 citations2011: 438 citations2012: 433 citations2013: 400 citations2014: 420 citations2015: 437 citations2016: 314 citations2017: 316 citations2018: 269 citations2019: 1,050 citations2020: 983 citations2021: 853 citations2022: 562 citations2023: 435 citations2024: 643 citations2025: 313 citations2026: 5 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,994 citing papers, 29.5% of this breakdownChina: 1,275 citing papers, 9.4% of this breakdownJapan: 820 citing papers, 6.1% of this breakdownUnited Kingdom: 819 citing papers, 6% of this breakdownItaly: 761 citing papers, 5.6% of this breakdownGermany: 699 citing papers, 5.2% of this breakdownFrance: 549 citing papers, 4% of this breakdownCanada: 473 citing papers, 3.5% of this breakdownNetherlands: 405 citing papers, 3% of this breakdownSouth Korea: 337 citing papers, 2.5% of this breakdownSpain: 322 citing papers, 2.4% of this breakdownAustralia: 244 citing papers, 1.8% of this breakdown
0%29.5%Other 21%

Fields

  • Medicine64.5%
  • Biochemistry, Genetics and Molecular Biology26.5%
  • Immunology and Microbiology1.9%
  • Computer Science1.8%
  • Engineering1.7%
  • Pharmacology, Toxicology and Pharmaceutics1.4%
  • Other2.2%

Topics

  • Pancreatic and Hepatic Oncology Research5.5%
  • Hepatocellular Carcinoma Treatment and Prognosis4.7%
  • Cholangiocarcinoma and Gallbladder Cancer Studies2.9%
  • Liver Disease Diagnosis and Treatment2.3%
  • Pancreatitis Pathology and Treatment2.1%
  • Gastric Cancer Management and Outcomes2%
  • Other80.5%

Coauthors

All papers

Open in search
  1. Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene

    Authors: , , , , , , , , , , - Cancer Cell 2009 cited by 936

  2. Consensus statement on the pathology of IgG4-related disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ji Kon Ryu, Takako Saeki, Dushyant V. Sahani, Thomas C. Smyrk, James R. Stone, Masayuki Takahira, George Webster, Motohisa Yamamoto, Giuseppe Zamboni, Hisanori Umehara, John H. Stone - Modern Pathology 2012 cited by 2,577

  3. Development and validation of a histological index for UC

    Authors: , , , , , , , , , , , , , , , , , , , , - Gut 2015 cited by 349

  4. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2004 cited by 1,957

  5. Microneedles for Drug Delivery via the Gastrointestinal Tract

    Authors: , , , , , , , , - Journal of Pharmaceutical Sciences 2014 cited by 197

  6. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer

    Authors: , , , , , , , , , , - Genes & Development 2006 cited by 652

  7. Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease−Associated Colorectal Cancers

    Authors: , , , , , , , , , , , , , , , , - Gastroenterology 2016 cited by 268

  8. An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2021 cited by 104

  9. Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2006 cited by 1,296

  10. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , - Hepatology 2013 cited by 359

  11. The emerging role of histologic disease activity assessment in ulcerative colitis

    Authors: , , , , , - Gastrointestinal Endoscopy 2018 cited by 147

  12. Epigallocatechin Gallate Induces Hepatic Stellate Cell Senescence and Attenuates Development of Hepatocellular Carcinoma

    Authors: , , , , , , , , , , , - Cancer Prevention Research 2020 cited by 36

  13. Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen–positive myeloid cell infiltration in mice

    Authors: , , , , , , , , , , , , - Hepatology 2013 cited by 213

  14. Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Augusto Villanueva, Angelo Sangiovanni, Massimo Iavarone, Massimo Colombo, Josep M. Llovet, Aravind Subramanian, Andrew M. Tager, Scott L. Friedman, Thomas F. Baumert, Myron Schwarz, Raymond T. Chung, Kenneth K. Tanabe, Bin Zhang, Bryan C. Fuchs, Yujin Hoshida - Cancer Cell 2016 cited by 210

  15. Ultrasound-mediated gastrointestinal drug delivery

    Authors: , , , , , , , , , , , , - Science Translational Medicine 2015 cited by 135

  16. Pancreatic Ductal Adenocarcinoma

    Authors: , , , , , , , , , , , , - Annals of Surgery 2012 cited by 422

  17. Histopathologic Features of Colitis Due to Immunotherapy With Anti-PD-1 Antibodies

    Authors: , , , - The American Journal of Surgical Pathology 2017 cited by 187

  18. An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis

    Authors: , , , , , , , , , , , , - Nature Protocols 2015 cited by 120

  19. Molecular imaging of oxidized collagen quantifies pulmonary and hepatic fibrogenesis

    Authors: , , , , , , , , , , , , , , , , , - JCI Insight 2017 cited by 78

  20. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease

    Authors: , , - Journal of Crohn s and Colitis 2022 cited by 45

  21. The "Retinoic Acid Syndrome" in Acute Promyelocytic Leukemia

    Authors: , , , , - Annals of Internal Medicine 1992 cited by 716

  22. Standardized measurement of the future liver remnant prior to extended liver resection: Methodology and clinical associations

    Authors: , , , , , , , , , , - Surgery 2000 cited by 689

  23. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases

    Authors: , , , , , - British journal of surgery 2007 cited by 537

  24. MET Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2011 cited by 430